Concepedia
Publication | Open Access
Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma
119
Citations
16
References
2018
Year
ClinicalTrials.gov identifier: NCT02181634.
Page 1